Bio-Path Holdings, Inc. Recorded Big Gain
Bio-Path Holdings, Inc. (BPTH:NASDAQ) rocketted at $1.49, a gain of 122.7%. On Thu, Dec 19, 2024, BPTH:NASDAQ hit a New 2-Week High of $1.49. The stock got featured on our News Catalysts scanner on Thu, Dec 19, 2024 at 08:16 AM in the 'BIOTECH' category. From Thu, Dec 05, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Dec 19, 2024 at $3.39 with a volume of 112M+.
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 409.59%
- Nvni Group Limited (NVNI:NASDAQ), 317.19%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 122.72%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 92.42%
- Trio Petroleum Corp. (TPET:NYSEMKT), 79.16%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 64.56%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 60.78%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 56.25%
- Cara Therapeutics, Inc. (CARA:NASDAQ), 56.01%